Biolojic Design Appoints Ronald Herbst, Ph.D., as Chief Scientific Officer
/PRNewswire/ -- Biolojic Design, a pioneer in the use of artificial intelligence (AI) in antibody design, today announced the appointment of Ronald Herbst,...
Stay updated with breaking news from Biolojic Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Biolojic Design, a pioneer in the use of artificial intelligence (AI) in antibody design, today announced the appointment of Ronald Herbst,...
Press release content from Business Wire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced a new strategic plan focused on prioritizing key research and development efforts that will...
/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced a new strategic plan focused on prioritizing key research and development efforts that will...
Biolojic Design will conduct the trial for cancer patients in Australia with a new type of drug that makes full use of computational biology and big data